PTCT News and Press, PTC Therapeutics Inc. From 12/05/23

2023-12-05 17:53:48 ET More on PTC Therapeutics PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call Transcript PTC Therapeutics stock slides after Citi downgrades to Sell PTC Therapeutics GAAP EPS of -$1.76 misses by $0.70, revenue of $196.6M misses by $15.07M ...

PTC Therapeutics Provides Updates on Translarna™ Regulatory Activities PR Newswire SOUTH PLAINFIELD, N.J. , Dec. 5, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today an update on Translarna™ (ataluren) regulatory activities ...

2023-10-29 06:11:08 ET PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Conference Call February 08, 2023, 9:00 AM ET Company Participants Jane Hanlon - Associate Director, Investor Relations Matthew Klein - Chief Executive Officer Eric Pauwels - Chief Business Off...

2023-10-27 09:20:56 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Align Technology (NASDAQ: ALGN ) stock is on the move Friday after the Invisalign maker announced a $250 million share repurchase program . Align Technology notes that this ...

2023-10-27 09:08:01 ET PTC Therapeutics ( NASDAQ: PTCT ) plunged ~22% premarket on Friday after the Citi downgraded recommendation on its stock to Sell/High Risk. SA Quant system rates the stock as Hold The downgrade follows the company's third quarter earnings a...

2023-10-26 18:02:05 ET Gainers: CVRx ( VRX ) +29% . Eargo ( EAR ) +28% . DexCom ( DXCM ) +15% . Masimo Corporation ( MASI ) +13% . Groupon ( GRPN ) +9% . Losers: Enphase Energy ( ENPH ) -17% . PTC Therapeutics...

2023-10-26 16:28:40 ET More on PTC Therapeutics PTC Therapeutics: Struggling Still But Potential Remains PTC Therapeutics, Inc. (PTCT) Q2 2023 Earnings Call Transcript PTC Therapeutics Q3 2023 Earnings Preview Royalty Pharma to buy up to $1.5B of PTC Therapeu...

PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results PR Newswire – Third quarter 2023 total revenues of $197 million and remain on target for 2023 revenue guidance – – PTC strengthened its financial position fo...

PTC Therapeutics Inc. (PTCT) is expected to report $-0.85 for Q3 2023

2023-10-19 19:02:30 ET A new royalty deal was the fuel that powered biotech PTC Therapeutics (NASDAQ: PTCT) stock to a 15% gain on Thursday. That arrangement, which covers PTC's spinal muscular atrophy (SMA) treatment Evrysdi, features a hefty upfront payment that could also bring i...